Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/41189
Title: The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin: A randomised trial
Authors: Kochawan Boonyawat
Luqi Wang
Alejandro Lazo-Langner
Michael J. Kovacs
Erik Yeo
Terri Schnurr
Sam Schulman
Mark A. Crowther
McMaster University
Western University
University of Toronto
St. Joseph's Healthcare Hamilton
Mahidol University
Keywords: Medicine
Issue Date: 1-Sep-2016
Citation: Thrombosis and Haemostasis. Vol.116, No.3 (2016), 480-485
Abstract: © Schattauer 2016. The anticoagulant effect of warfarin is influenced by variations in vitamin K intake. Concomitant use of daily low-dose oral vitamin K (LDVK) and warfarin may improve INR stability. We hypothesise that administration of LDVK improves INR control. To test this hypothesis we performed a multi-centre, placebo-controlled, randomised trial conducted at four university-affiliated hospitals in Canada. Patients on chronic warfarin therapy received oral vitamin K 150 mcg daily or a matching placebo for a total of six months after a one-month run in period. The primary outcome was a comparison of mean time in therapeutic range (TTR) in LDVK and placebo group during a six-monthperiod. The secondary outcome was number of INR excursions <1.5 or >4.5. There was no significant difference in the final TTR between the two groups (65.1 % vs 66 %, p =0.8). Mean TTR in both LDVK and placebo groups were statistically increased compared with prior to the study. The number of INR excursions were significantly decreased in the LDVK group (9.4 % and 5.4 %, absolute difference [pre- minus post-] = 4 %, 95 % CI, 2 to 6 %, p-value <0.001). We conclude that LDVK administration did not increase mean TTR, but did decrease the number of INR excursions. The observed improvement in mean TTR in both groups suggests that more attentive monitoring of warfarin therapy, rather than LDVK, was responsible for the improvement in TTR observed. The reduced excursions suggest that LDVK did reduce extreme INR variation. The study is registered at www.ClinicalTrial.gov# NCT00990158.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84989172865&origin=inward
http://repository.li.mahidol.ac.th/dspace/handle/123456789/41189
ISSN: 03406245
Appears in Collections:Scopus 2016-2017

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.